From research to licensure and beyond: clinical development of MenB-FHbp, a broadly protective meningococcal B vaccine

From research to licensure and beyond: clinical development of MenB-FHbp, a broadly protective meningococcal B vaccine

Introduction: Given the characteristics of meningococcal carriage and transmission and the sudden, often severe onset and long-term consequences of disease, vaccination can most effectively provide large-scale control of invasive disease. Six serogroups (A, B, C, W, X, and Y) cause nearly all mening...

Full description

Bibliographic Details
Main Authors:	John L. Perez, Judith Absalon, Johannes Beeslaar, Paul Balmer, Kathrin U. Jansen, Thomas R. Jones, Shannon Harris, Laura J. York, Qin Jiang, David Radley, Annaliesa S. Anderson, Graham Crowther, Joseph J. Eiden
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2018-06-01
Series:	Expert Review of Vaccines
Subjects:	bivalent rlp2086 factor h binding protein menb-fhbp meningococcal serogroup b disease trumenba® vaccine coverage
Online Access:	http://dx.doi.org/10.1080/14760584.2018.1483726

Similar Items

Meningococcal serogroup B vaccines: Estimating breadth of coverage
by: Robert G. K. Donald, et al.
Published: (2017-02-01)

MenB-FHbp Vaccine Protects Against Diverse Meningococcal Strains in Adolescents and Young Adults: Post Hoc Analysis of Two Phase 3 Studies
by: Johannes Beeslaar, et al.
Published: (2020-07-01)

A physician’s guide to the 2-dose schedule of MenB-FHbp vaccine
by: Angee McDaniel, et al.
Published: (2019-11-01)

Commentary: Variant Signal Peptides of Vaccine Antigen, FHbp, Impair Processing Affecting Surface Localization and Antibody-Mediated Killing in Most Meningococcal Isolates
by: Paul Liberator, et al.
Published: (2020-11-01)

Meningococcal serogroup B vaccination series initiation in the United States: A real-world claims data analysis
by: Elizabeth R. Packnett, et al.
Published: (2023-01-01)

Introduction of a second MenB vaccine into Europe – needs and opportunities for public health
by: Jamie Findlow, et al.
Published: (2019-03-01)

Cost calculator for mass vaccination response to a US college campus outbreak of serogroup B meningococcal disease
by: Elizabeth M. La, et al.
Published: (2019-04-01)

Sex, Age, and Race Effects on Immunogenicity of MenB-FHbp, A Bivalent Meningococcal B Vaccine: Pooled Evaluation of Clinical Trial Data
by: Johannes Beeslaar, et al.
Published: (2020-07-01)

Meningococcal B Immunisation in Adults and Potential Broader Immunisation Strategies: A Narrative Review
by: George Kassianos, et al.
Published: (2023-07-01)

Concomitant administration of meningococcal vaccines with other vaccines in adolescents and adults: a review of available evidence
by: Justine Alderfer, et al.
Published: (2019-09-01)

Genetic Features of a Representative Panel of 110 Meningococcal B Isolates to Assess the Efficacy of Meningococcal B Vaccines
by: Alessandro Muzzi, et al.
Published: (2022-10-01)

Emerging experience with meningococcal serogroup B protein vaccines
by: Daniela Toneatto, et al.
Published: (2017-05-01)

Safety profile of MenB-FHBp vaccine among adolescents: data from surveillance of Adverse Events Following Immunization in Puglia (Italy), 2018–2020
by: Pasquale Stefanizzi, et al.
Published: (2022-01-01)

Use of expanded Neisseria meningitidis serogroup B panels with the serum bactericidal antibody assay for the evaluation of meningococcal B vaccine effectiveness
by: Ray Borrow, et al.
Published: (2023-12-01)

Anti-Factor H Antibody Reactivity in Young Adults Vaccinated with a Meningococcal Serogroup B Vaccine Containing Factor H Binding Protein
by: Kelsey Sharkey, et al.
Published: (2019-08-01)

Neisseria meningitidis serogroup B carriage by adolescents and young adults living in Milan, Italy: Prevalence of strains potentially covered by the presently available meningococcal B vaccines
by: Leonardo Terranova, et al.
Published: (2018-05-01)

Molecular characterization of invasive Neisseria meningitidis isolates collected in Lithuania (2009-2019) and estimation of serogroup B meningococcal vaccine 4CMenB and MenB-Fhbp coverage
by: Emilija Sereikaitė, et al.
Published: (2023-02-01)

Summary of the NACI Statement on the Use of Bivalent Factor H Binding Protein Meningococcal Serogroup B (MenB-fHBP) Vaccine for the Prevention of Meningococcal B Disease
by: Robyn Harrison, et al.
Published: (2020-02-01)

Global epidemiology of serogroup B meningococcal disease and opportunities for prevention with novel recombinant protein vaccines
by: Rodolfo Villena, et al.
Published: (2018-05-01)

Past, present, and future policy considerations regarding meningococcal vaccination in the United States
by: Diana E. Clements, et al.
Published: (2024-12-01)

A critical analysis of serogroup B meningococcal disease burden in Brazil (2001–2015): implications for public health decisions
by: Luciana Andrea Digieri Chicuto, et al.
Published: (2020-08-01)

Variant Signal Peptides of Vaccine Antigen, FHbp, Impair Processing Affecting Surface Localization and Antibody-Mediated Killing in Most Meningococcal Isolates
by: Ronni A. G. da Silva, et al.
Published: (2019-12-01)

Safety and immunogenicity of meningococcal (Groups A and C) polysaccharide vaccine in children 2 to 6 y of age in China: a randomized, active-controlled, non-inferiority study
by: Feng-Cai Zhu, et al.
Published: (2021-03-01)

Proceedings of the Expert Consensus Group meeting on meningococcal serogroup B disease burden and prevention in India
by: Anand P. Dubey, et al.
Published: (2022-01-01)

Corrigendum: Variant Signal Peptides of Vaccine Antigen, FHbp, Impair Processing Affecting Surface Localization and Antibody-Mediated Killing in Most Meningococcal Isolates
by: Ronni A. G. da Silva, et al.
Published: (2020-02-01)

Effectiveness of quadrivalent meningococcal conjugate vaccine against meningococcal carriage and genotype character changes: A secondary analysis of prospective cohort study in Korean military trainees
by: Young Rong Kim, et al.
Published: (2024-09-01)

Characteristics of YouTube videos about the meningococcal B vaccine (4CMenB)
by: Ignacio Hernández-García, et al.
Published: (2020-10-01)

Why the Anti-Meningococcal B Vaccination during Adolescence Should Be Implemented in Italy: An Overview of Available Evidence
by: Sara Boccalini, et al.
Published: (2020-10-01)

Protecting UK adolescents and adults against meningococcal serogroup B disease
by: Andrew Vyse, et al.
Published: (2018-03-01)

Parental awareness and utilization of meningococcal serogroup B vaccines in the United States
by: Amit Srivastava, et al.
Published: (2020-07-01)

Awareness, Attitudes, and Practices Toward Meningococcal B Vaccine among Pediatricians in Italy
by: Pietro Ferrara, et al.
Published: (2018-12-01)

Serogroup B Meningococcal Disease Vaccine Recommendations at a University, New Jersey, USA, 2016
by: Heidi M. Soeters, et al.
Published: (2017-05-01)

Invasive meningococcal disease in South-Eastern European countries: Do we need to revise vaccination strategies?
by: Georgina Tzanakaki, et al.
Published: (2024-12-01)

Transmissibility and pathogenicity of the emerging meningococcal serogroup W sequence type-11 complex South American strain: a mathematical modeling study
by: Matthieu Domenech de Cellès, et al.
Published: (2020-04-01)

Serum bactericidal activity against circulating and reference strains of meningococcal serogroup B in the United States: A review of the strain coverage of meningococcal serogroup B (MenB) vaccines in adolescents and young adults
by: Jessica Presa, et al.
Published: (2023-01-01)

Serogroup Y Meningococcal Disease, Colombia
by: Clara Inés Agudelo, et al.
Published: (2008-06-01)

Determinants of Meningococcal Vaccination Coverage and Adherence: A Targeted Literature Review Supporting a 16-year-old Healthcare Visit
by: Oscar Herrera-Restrepo, et al.
Published: (2023-05-01)

Culture-Confirmed Invasive Meningococcal Disease in Canada, 2010 to 2014: Characterization of Serogroup B <italic toggle="yes">Neisseria meningitidis</italic> Strains and Their Predicted Coverage by the 4CMenB Vaccine
by: Raymond S. W. Tsang, et al.
Published: (2020-04-01)

Understanding the Sequelae of Invasive Meningococcal Disease in the United States
by: Gary S. Marshall, et al.
Published: (2024-08-01)

Fatal meningococcal meningitis in a HIV-infected patient caused by serogroup C Neisseria meningitidis belonging to the non-hypervirulent clonal complex ST-60 (cc60)
by: Claudia Ferreira de Andrade, et al.